Major trends in and development prospects for the Russian market of injectable neuroprotectors


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. The positive effects of neuroprotectors are due to their widespread use to rehabilitate patients after stroke, head injuries, and prior neurological diseases. Neuroprotective drugs are most frequently used as injections. There is no publicly available marketing research on this pharmaceutical market segment. Objective: to analyze sales and price levels and pricing trends on the Russian market of injectable neuroprotectors, to identify major trends in the growth of this pharmaceutical market segment, and to assess prospects for its development. Material and methods. The research was based on data from the retail and hospital audits of drug sales in Russia, which were provided by IMS Health and Quintiles (IQVIA). Results. Based on the data of the retail and hospital audits of drug sales, the investigators calculated the volumes of sales of injectable formulations of neuroprotectors in monetary and physical terms. They studied the time course of changes in sales volumes, drug price levels, and drug pricing trends and the analysis of import substitution. Conclusion. The research has shown the prospects of the Russian market of injectable neuroprotectors due to the growth of drug sales and to the increase in the share of Russian medicines.

Full Text

Restricted Access

About the authors

Igor A. Narkevich

Saint Petersburg State Chemopharmaceutical University

Email: igor.narkevich@pharminnotech.com
Rector; Head of the Department of Management and Economics of Pharmacy, Doctor of Pharmaceutical Sciences, рrofessor. 14A, Prof. Popov St., Saint Petersburg 197376, Russian Federation

Alexander S. Orlov

Saint Petersburg State Chemopharmaceutical University

Email: alexander.orlov@pharminnotech.com
Docent of the Department of Economics and Management 14A, Prof. Popov St., Saint Petersburg 197376, Russian Federation

Tatiana Y. Delvig-Kamenskaya

Saint Petersburg State Chemopharmaceutical University

Email: tatiana.delvig-kamenskaya@pharminnotech.com
Docent of the Department of Economics and Management 14A, Prof. Popov St., Saint Petersburg 197376, Russian Federation

Irina E. Smekhova

Saint Petersburg State Chemopharmaceutical University

Email: Irina.Smekhova@pharminnotech.com
Professor of the Department of Technology of Medicinal Forms, Doctor of Pharmaceutical Sciences. 14A, Prof. Popov St., Saint Petersburg 197376, Russian Federation

Karina I. Badirova

Saint Petersburg State Chemopharmaceutical University

Email: Karina.Badirova@pharminnotech.com
postgraduate student of the Department of medical and pharmaceutical commodity science 14A, Prof. Popov St., Saint Petersburg 197376, Russian Federation

References

  1. Афанасьев В.В. Азбука нейроцитопротекции. СПб: СТЕЛЛА, 2016; 280.
  2. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology, 2008; 55(3): 363-9.
  3. Фармацевтический рынок России. Итоги 2017 года: аналитический отчет. - М.: ЗАО Группа «ДСМ», 2018; 110.
  4. Наркевич И.А., Лин А.А., Орлов А.С. Сравнительный анализ уровня и динамики цен в коммерческом розничном секторе фармацевтического рынка России и Санкт-Петербурга. Фармация, 2014; 8:13-20.
  5. Орлов А.С. Ценовой анализ в государственном регулировании ценообразования на фармацевтическом рынке. Экономика и управление: научно-практический журнал, 2008; 6 (86): 61-5.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies